BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
GATA1
,
Fatty acid metabolic process
,
Diabetes mellitus
,
Kidney
,
Alcohol
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Mazindol
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SLC6A2
SLC6A3
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
dopamine uptake
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS
MODULE_162
MODULE_218
Sodium:neurotransmitter symporter
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Efficacy and safety of the metformin-mazindol anorectic combination in rat.
Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects.
Altered levels of dopamine transporter in the frontal pole and the striatum in mood disorders: A pos…
Diethylpropion and mazindol: An end to the discussion?
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a mono…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Mazindol for Cocaine Abuse - 2
An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy
Mazindol in Children With ADHD : Open-label, Efficacy, Safety and Pharmacokinetic Pilot Trial
Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ